Author | Howard A "Skip" Burris, III, MD | OncLive

Author | Howard A "Skip" Burris, III, MD

Articles

Dr. Burris on the Impact of the ASCO Annual Meeting

May 28, 2015

Video

Howard Burris, III, MD, chief medical officer and executive director of Drug Development at the Sarah Cannon Research Institute discusses the importance of the ASCO annual meeting, taking place May 29 - June 2.

Dr. Howard Burris Discusses the mTOR Inhibitor Everolimus

September 05, 2012

Video

Dr. Howard Burris, from the Sarah Cannon Research Institute, Discusses the mTOR Inhibitor Everolimus for HER2-Negative Breast Cancer.

Dr. Burris on Using Recurrence Scores to Predict pCR

February 23, 2012

Video

Dr. Howard Burris from Sarah Cannon Research Institute Discusses Recurrence Scores Predicting pCR

x